Intended for healthcare professionals

News In Brief


BMJ 2006; 333 doi: (Published 07 December 2006) Cite this as: BMJ 2006;333:1188

Pfizer halts trial of heart drug after deaths:The drug giant Pfizer has stopped the trial of its drug torcetrapid, which is designed to increase HDL cholesterol concentrations, after scientists monitoring the trial noted that 82 people taking the drug along with the company's statin, atorvastatin (Lipitor), had died, whereas 51 people taking Lipitor alone had died. Pfizer had been expected to apply for a licence for …

View Full Text

Log in

Log in through your institution


* For online subscription